Product Description: ASN90 is a specific and orally active O-GlcNAcase (OGA) enzyme inhibitor with IC50 value of 10.2 nM. ASN90 can be used for the research of neurodegenerative diseases, such as tauopathies and α-synucleinopathies[1].
Applications: Neuroscience-Neurodegeneration
Formula: C17H21N5O3S
References: [1]Permanne B, et al. O-GlcNAcase Inhibitor ASN90 is a Multimodal Drug Candidate for Tau and α-Synuclein Proteinopathies. ACS Chem Neurosci. 2022 Apr 20;13(8):1296-1314.
CAS Number: 1884154-02-2
Molecular Weight: 375.45
Compound Purity: 99.63
Research Area: Neurological Disease
Solubility: DMSO : 100 mg/mL (ultrasonic;warming;heat to 80°C)